세계의 세포치료 제조 시장 규모, 점유율, 동향, 업계 분석 : 공급원별, 세포 유형별, 적응증별, 수술 규모별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Cell Therapy Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Source, By Cell Type, By Indication, By Scale of Operation, By End User, and By Region - Market Forecast, 2025-2034

US $ 4,250 ￦ 6,048,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250 ￦ 7,471,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250 ￦ 8,894,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

Polaris Market Research의 최신 조사에 따르면 세포치료 제조 시장 규모는 2034년까지 241억 8,000만 달러에 달할 전망입니다. 이 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.

세포치료제 제조는 재생의료, 종양학, 면역 관련 질환에 사용되는 자가 및 동종 세포 기반 치료제의 대규모 생산 및 가공을 말합니다. 이러한 제조 공정은 세포의 생존성, 유전적 안정성, 치료 효과를 보장하기 위해 엄격한 규제 기준 하에 진행됩니다.

시장 성장의 원동력은 암과 만성 퇴행성 질환의 전 세계적인 발병률 증가로 첨단 세포 기반 면역치료에 대한 수요를 견인하고 있습니다. 재생의료 분야의 R&D 비용 증가는 정부의 자금 지원 및 유리한 규제 프레임워크와 함께 제품 개발을 더욱 가속화시키고 있습니다.

세포치료제 제조 시장 : 분석 개요

공급원별로는 자가 세포 치료 분야가 2024년 가장 큰 시장 점유율을 차지했습니다. 이는 면역거부반응의 위험을 줄이고 종양학 및 희귀 유전성 질환의 치료 결과를 개선하는 환자 특이적 치료법의 채택이 증가하고 있기 때문입니다.

세포 유형별로는 T세포 분야가 시장을 독점하고 있습니다. 이는 복잡한 치료용 단백질의 생산 효율이 높고, 생물제제 제조에 있으며, 보다 우수한 효능과 안전성이 보장되기 때문입니다.

적응증별로는 파킨슨병, 다발성경화증, 척수손상 등의 질환에 대한 줄기세포를 이용한 재생치료 임상연구가 활발해지면서 신경질환 분야가 가장 가파른 성장이 예상되고 있습니다.

수술 규모별로는 다양한 치료 영역에서 임상시험 건수가 증가함에 따라 임상 분야가 2024년 압도적인 점유율을 차지했습니다.

최종사용자별로는 학계 및 연구기관이 자금 지원 및 세포치료제 공동연구를 통해 가장 빠르게 성장할 것으로 예측됩니다.

북미는 재생의료 연구를 위한 정부 및 민간 자금의 확대에 힘입어 2024년 세계 세포치료제 제조 시장을 독점했습니다.

아시아태평양은 바이오테크놀러지의 확대와 재생의료에 대한 투자에 힘입어 꾸준한 성장세를 보였습니다.

세계의 주요 시장 기업에는 Lonza Group AG, Minaris Regenerative Medicine, Merck KGaA, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories, Cell Therapies Pty Ltd., Fujifilm Cellular Dynamics Inc., Bayer AG, AGC Biologics, Cellistic, Bio-Techne 등이 있습니다.

목차

제1장 서론

제2장 개요

제3장 분석 방법

제4장 세계의 세포치료 제조 시장 인사이트

• 시장 스냅숏
• 세포치료 제조 시장 역학
  • 촉진요인과 기회
    • 세계 연구개발비의 증가
    • 세계 암환자의 증가
  • 억제요인과 과제
    • 높은 제조 비용
• PESTLE 분석
• 세포치료 제조 시장의 동향
• 밸류체인 분석

제5장 세계의 세포치료 제조 시장 : 공급원별

• 주요 분석 결과
• 서론
• 자가 세포치료
• 동종 세포치료

제6장 세계의 세포치료 제조 시장 : 세포 유형별

• 주요 분석 결과
• 서론
• T세포
• 줄기세포
• 천연 킬러(NK) 세포
• 수지상세포
• 기타

제7장 세계의 세포치료 제조 시장 : 적응증별

• 주요 분석 결과
• 서론
• 종양
• 심혈관질환
• 신경질환
• 정형외과·근골격계 질환
• 자가면역질환
• 기타

제8장 세계의 세포치료 제조 시장 : 수술 규모별

• 주요 분석 결과
• 서론
• 임상
• 출시
• 전임상

제9장 세계의 세포치료 제조 시장 : 최종사용자별

• 주요 분석 결과
• 서론
• 병원·전문 클리닉
• 제약·바이오테크놀러지 기업
• 학술·연구기관

제10장 세계의 세포치료 제조 시장 : 지역별

• 주요 분석 결과
• 서론
  • 세포치료 제조 시장 분석 : 지역별(2020-2034년)
• 북미
  • 북미 : 공급원별(2020-2034년)
  • 북미 : 세포 유형별(2020-2034년)
  • 북미 : 적응증별(2020-2034년)
  • 북미 : 수술 규모별(2020-2034년)
  • 북미 : 최종사용자별(2020-2034년)
  • 미국
  • 캐나다
• 유럽
  • 유럽 : 공급원별(2020-2034년)
  • 유럽 : 세포 유형별(2020-2034년)
  • 유럽 : 적응증별(2020-2034년)
  • 유럽 : 수술 규모별(2020-2034년)
  • 유럽 : 최종사용자별(2020-2034년)
  • 영국
  • 프랑스
  • 독일
  • 이탈리아
  • 스페인
  • 네덜란드
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 아시아태평양 : 공급원별(2020-2034년)
  • 아시아태평양 : 세포 유형별(2020-2034년)
  • 아시아태평양 : 적응증별(2020-2034년)
  • 아시아태평양 : 수술 규모별(2020-2034년)
  • 아시아태평양 : 최종사용자별(2020-2034년)
  • 중국
  • 인도
  • 말레이시아
  • 일본
  • 인도네시아
  • 한국
  • 호주
  • 기타 아시아태평양
• 중동 및 아프리카
  • 중동 및 아프리카 : 공급원별(2020-2034년)
  • 중동 및 아프리카 : 세포 유형별(2020-2034년)
  • 중동 및 아프리카 : 적응증별(2020-2034년)
  • 중동 및 아프리카 : 수술 규모별(2020-2034년)
  • 중동 및 아프리카 : 최종사용자별(2020-2034년)
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 남아프리카공화국
  • 기타 중동 및 아프리카
• 라틴아메리카
  • 라틴아메리카 : 공급원별(2020-2034년)
  • 라틴아메리카 : 세포 유형별(2020-2034년)
  • 라틴아메리카 : 적응증별(2020-2034년)
  • 라틴아메리카 : 수술 규모별(2020-2034년)
  • 라틴아메리카 : 최종사용자별(2020-2034년)
  • 멕시코
  • 브라질
  • 아르헨티나
  • 기타 라틴아메리카

제11장 경쟁 구도

• 사업 확대·기업 인수 분석
  • 사업 확대
  • 기업 인수
• 제휴/협업/합의/공개

제12장 기업 개요

• AGC Biologics
• Bayer AG
• Bio-Techne
• Catalent, Inc.
• Cell Therapies Pty Ltd.
• Cellistic
• Charles River Laboratories
• Fujifilm Cellular Dynamics Inc.
• Lonza Group AG
• Merck KGaA
• Minaris Regenerative Medicine
• Thermo Fisher Scientific Inc.

KSA

영문 목차

영문목차

The cell therapy manufacturing market size is expected to reach USD 24.18 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Therapy Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Source, By Cell Type, By Indication, By Scale of Operation, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cell therapy manufacturing refers to the large-scale production and processing of autologous and allogeneic cell-based therapies used for regenerative medicine, oncology, and immune-related disorders. These manufacturing processes are conducted under stringent regulatory standards to ensure cell viability, genetic stability, and therapeutic efficacy.

The market growth is fueled by the increasing global incidence of cancer and chronic degenerative diseases, which is driving demand for advanced cell-based immunotherapies. Rising R&D expenditure in regenerative medicine coupled with government funding and favorable regulatory frameworks is further accelerating product development.

Cell Therapy Manufacturing Market Report Highlights

Based on source, the autologous cell therapy segment accounted for the largest market share in 2024, due to the growing adoption of patient-specific therapies offering reduced risk of immune rejection and improved treatment outcomes in oncology and rare genetic disorders.

Based on cell type, the T-cell segment dominated the market, driven by its high efficiency in producing complex therapeutic proteins that ensures better efficacy and safety in biologics manufacturing

Based on indication, the neurological disorders segment is expected to witness the fastest growth, fueled by increasing clinical research in stem cell-based regenerative therapies for conditions such as Parkinson's disease, multiple sclerosis, and spinal cord injuries.

Based on scale of operation, the clinical segment held the dominant share in 2024, due to the rising number of clinical trials across various therapeutic areas.

Based on end user, the academic & research institutes is expected to witness the fastest growth, driven by funding and cell therapy collaborations.

North America dominated the global cell therapy manufacturing market in 2024, fueled by expanding government and private funding for regenerative medicine research.

Asia Pacific witnessed a steady growth, driven by biotech expansion and regenerative medicine investments.

A few global key market players include Lonza Group AG, Minaris Regenerative Medicine, Merck KGaA, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories, Cell Therapies Pty Ltd., Fujifilm Cellular Dynamics Inc., Bayer AG, AGC Biologics, Cellistic, and Bio-Techne.

Polaris Market Research has segmented the market report on the basis of source, cell type, indication, scale of operation, end user, and region:

By Source Outlook (Revenue, USD Billion, 2020-2034)

Autologous Cell Therapy

Allogeneic Cell Therapy

By Cell Type Outlook (Revenue, USD Billion, 2020-2034)

T-Cells

Stem Cells

Natural Killer (NK) Cells

Dendritic Cells

Others

By Indication (Revenue, USD Billion, 2020-2034)

Oncology

Cardiovascular Diseases

Neurological Disorders

Orthopedic & Musculoskeletal Disorders

Autoimmune Diseases

Others

By Scale of Operation (Revenue, USD Billion, 2020-2034)

Clinical

Commercial

Pre-clinical

By End User (Revenue, USD Billion, 2020-2034)

Hospitals & Specialty Clinics

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Cell Therapy Manufacturing Market Insights

• 4.1. Cell Therapy Manufacturing Market - Market Snapshot
• 4.2. Cell Therapy Manufacturing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Global R&D Expenditure
    • 4.2.1.2. Increasing Global Cancer Cases
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Manufacturing Costs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Cell Therapy Manufacturing Market Trends
• 4.6. Value Chain Analysis

5. Global Cell Therapy Manufacturing Market, by Source

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
• 5.3. Autologous Cell Therapy
  • 5.3.1. Global Cell Therapy Manufacturing Market, by Autologous Cell Therapy, by Region, 2020-2034 (USD Billion)
• 5.4. Allogeneic Cell Therapy
  • 5.4.1.1. Global Cell Therapy Manufacturing Market, by Allogeneic Cell Therapy, by Region, 2020-2034 (USD Billion)

6. Global Cell Therapy Manufacturing Market, by Cell Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
• 6.3. T-Cells
  • 6.3.1. Global Cell Therapy Manufacturing Market, by T-Cells, by Region, 2020-2034 (USD Billion)
• 6.4. Stem Cells
  • 6.4.1. Global Cell Therapy Manufacturing Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
• 6.5. Natural Killer (NK) Cells
  • 6.5.1. Global Cell Therapy Manufacturing Market, by Natural Killer (NK) Cells, by Region, 2020-2034 (USD Billion)
• 6.6. Dendritic Cells
  • 6.6.1. Global Cell Therapy Manufacturing Market, by Dendritic Cells, by Region, 2020-2034 (USD Billion)
• 6.7. Others
  • 6.7.1. Global Cell Therapy Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cell Therapy Manufacturing Market, by Indication

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
• 7.3. Oncology
  • 7.3.1. Global Cell Therapy Manufacturing Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 7.4. Cardiovascular Diseases
  • 7.4.1. Global Cell Therapy Manufacturing Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
• 7.5. Neurological Disorders
  • 7.5.1. Global Cell Therapy Manufacturing Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
• 7.6. Orthopedic & Musculoskeletal Disorders
  • 7.6.1. Global Cell Therapy Manufacturing Market, by Orthopedic & Musculoskeletal Disorders, by Region, 2020-2034 (USD Billion)
• 7.7. Autoimmune Diseases
  • 7.7.1. Global Cell Therapy Manufacturing Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
• 7.8. Others
  • 7.8.1. Global Cell Therapy Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Cell Therapy Manufacturing Market, by Scale of Operation

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
• 8.3. Clinical
  • 8.3.1. Global Cell Therapy Manufacturing Market, by Clinical, by Region, 2020-2034 (USD Billion)
• 8.4. Commercial
  • 8.4.1. Global Cell Therapy Manufacturing Market, by Commercial, by Region, 2020-2034 (USD Billion)
• 8.5. Pre-clinical
  • 8.5.1. Global Cell Therapy Manufacturing Market, by Pre-clinical, by Region, 2020-2034 (USD Billion)

9. Global Cell Therapy Manufacturing Market, by End User

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
• 9.3. Hospitals & Specialty Clinics
  • 9.3.1. Global Cell Therapy Manufacturing Market, by Hospitals & Specialty Clinics, by Region, 2020-2034 (USD Billion)
• 9.4. Pharmaceutical & Biotechnology Companies
  • 9.4.1. Global Cell Therapy Manufacturing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
• 9.5. Academic & Research Institutes
  • 9.5.1. Global Cell Therapy Manufacturing Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)

10. Global Cell Therapy Manufacturing Market, by Geography

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Cell Therapy Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
• 10.3. Cell Therapy Manufacturing Market - North America
  • 10.3.1. North America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 10.3.2. North America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • 10.3.3. North America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • 10.3.4. North America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • 10.3.5. North America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.3.6. Cell Therapy Manufacturing Market - U.S.
    • 10.3.6.1. U.S.: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.3.6.2. U.S.: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.3.6.3. U.S.: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.3.6.4. U.S.: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.3.6.5. U.S.: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.3.7. Cell Therapy Manufacturing Market - Canada
    • 10.3.7.1. Canada: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.3.7.2. Canada: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.3.7.3. Canada: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.3.7.4. Canada: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.3.7.5. Canada: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
• 10.4. Cell Therapy Manufacturing Market - Europe
  • 10.4.1. Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 10.4.2. Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • 10.4.3. Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • 10.4.4. Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • 10.4.5. Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.6. Cell Therapy Manufacturing Market - UK
    • 10.4.6.1. UK: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.6.2. UK: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.6.3. UK: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.6.4. UK: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.6.5. UK: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.7. Cell Therapy Manufacturing Market - France
    • 10.4.7.1. France: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.7.2. France: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.7.3. France: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.7.4. France: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.7.5. France: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.8. Cell Therapy Manufacturing Market - Germany
    • 10.4.8.1. Germany: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.8.2. Germany: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.8.3. Germany: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.8.4. Germany: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.8.5. Germany: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.9. Cell Therapy Manufacturing Market - Italy
    • 10.4.9.1. Italy: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.9.2. Italy: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.9.3. Italy: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.9.4. Italy: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.9.5. Italy: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.10. Cell Therapy Manufacturing Market - Spain
    • 10.4.10.1. Spain: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.10.2. Spain: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.10.3. Spain: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.10.4. Spain: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.10.5. Spain: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.11. Cell Therapy Manufacturing Market - Netherlands
    • 10.4.11.1. Netherlands: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.11.2. Netherlands: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.11.3. Netherlands: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.11.4. Netherlands: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.11.5. Netherlands: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.12. Cell Therapy Manufacturing Market - Russia
    • 10.4.12.1. Russia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.12.2. Russia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.12.3. Russia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.12.4. Russia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.12.5. Russia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4.13. Cell Therapy Manufacturing Market - Rest of Europe
    • 10.4.13.1. Rest of Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.13.2. Rest of Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.13.3. Rest of Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.13.4. Rest of Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.13.5. Rest of Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
• 10.5. Cell Therapy Manufacturing Market - Asia Pacific
  • 10.5.1. Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 10.5.2. Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • 10.5.3. Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • 10.5.4. Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • 10.5.5. Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.6. Cell Therapy Manufacturing Market - China
    • 10.5.6.1. China: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.6.2. China: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.6.3. China: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.6.4. China: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.6.5. China: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.7. Cell Therapy Manufacturing Market - India
    • 10.5.7.1. India: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.7.2. India: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.7.3. India: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.7.4. India: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.7.5. India: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.8. Cell Therapy Manufacturing Market - Malaysia
    • 10.5.8.1. Malaysia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.8.2. Malaysia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.8.3. Malaysia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.8.4. Malaysia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.8.5. Malaysia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.9. Cell Therapy Manufacturing Market - Japan
    • 10.5.9.1. Japan: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.9.2. Japan: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.9.3. Japan: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.9.4. Japan: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.9.5. Japan: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.10. Cell Therapy Manufacturing Market - Indonesia
    • 10.5.10.1. Indonesia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.10.2. Indonesia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.10.3. Indonesia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.10.4. Indonesia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.10.5. Indonesia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.11. Cell Therapy Manufacturing Market - South Korea
    • 10.5.11.1. South Korea: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.11.2. South Korea: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.11.3. South Korea: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.11.4. South Korea: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.11.5. South Korea: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.12. Cell Therapy Manufacturing Market - Australia
    • 10.5.12.1. Australia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.12.2. Australia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.12.3. Australia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.12.4. Australia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.12.5. Australia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5.13. Cell Therapy Manufacturing Market - Rest of Asia Pacific
    • 10.5.13.1. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.13.2. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.13.3. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.13.4. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.13.5. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
• 10.6. Cell Therapy Manufacturing Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 10.6.2. Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • 10.6.3. Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • 10.6.4. Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • 10.6.5. Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.6.6. Cell Therapy Manufacturing Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.6.6.2. Saudi Arabia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.6.6.3. Saudi Arabia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.6.6.4. Saudi Arabia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.6.6.5. Saudi Arabia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.6.7. Cell Therapy Manufacturing Market - UAE
    • 10.6.7.1. UAE: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.6.7.2. UAE: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.6.7.3. UAE: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.6.7.4. UAE: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.6.7.5. UAE: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.6.8. Cell Therapy Manufacturing Market - Israel
    • 10.6.8.1. Israel: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.6.8.2. Israel: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.6.8.3. Israel: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.6.8.4. Israel: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.6.8.5. Israel: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.6.9. Cell Therapy Manufacturing Market - South Africa
    • 10.6.9.1. South Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.6.9.2. South Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.6.9.3. South Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.6.9.4. South Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.6.9.5. South Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.6.10. Cell Therapy Manufacturing Market - Rest of Middle East & Africa
    • 10.6.10.1. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.6.10.2. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.6.10.3. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.6.10.4. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.6.10.5. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
• 10.7. Cell Therapy Manufacturing Market - Latin America
  • 10.7.1. Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 10.7.2. Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • 10.7.3. Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • 10.7.4. Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • 10.7.5. Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.7.6. Cell Therapy Manufacturing Market - Mexico
    • 10.7.6.1. Mexico: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.7.6.2. Mexico: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.7.6.3. Mexico: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.7.6.4. Mexico: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.7.6.5. Mexico: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.7.7. Cell Therapy Manufacturing Market - Brazil
    • 10.7.7.1. Brazil: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.7.7.2. Brazil: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.7.7.3. Brazil: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.7.7.4. Brazil: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.7.7.5. Brazil: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.7.8. Cell Therapy Manufacturing Market - Argentina
    • 10.7.8.1. Argentina: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.7.8.2. Argentina: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.7.8.3. Argentina: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.7.8.4. Argentina: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.7.8.5. Argentina: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.7.9. Cell Therapy Manufacturing Market - Rest of Latin America
    • 10.7.9.1. Rest of Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.7.9.2. Rest of Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.7.9.3. Rest of Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.7.9.4. Rest of Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.7.9.5. Rest of Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. AGC Biologics
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Bayer AG
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. Bio-Techne
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. Catalent, Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. Cell Therapies Pty Ltd.
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. Cellistic
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Benchmarking
  • 12.6.4. Recent Development
• 12.7. Charles River Laboratories
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Benchmarking
  • 12.7.4. Recent Development
• 12.8. Fujifilm Cellular Dynamics Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Benchmarking
  • 12.8.4. Recent Development
• 12.9. Lonza Group AG
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Benchmarking
  • 12.9.4. Recent Development
• 12.10. Merck KGaA
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Benchmarking
  • 12.10.4. Recent Development
• 12.11. Minaris Regenerative Medicine
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Benchmarking
  • 12.11.4. Recent Development
• 12.12. Thermo Fisher Scientific Inc.
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Benchmarking
  • 12.12.4. Recent Development

관련자료